Sean Lee Analyst PerformanceVice President, Equity Research at HC WainwrightSean Lee is a stock analyst at HC Wainwright in the healthcare sector, covering 13 publicly traded companies. Over the past year, Sean Lee has issued 24 stock ratings, including buy and hold recommendations. While full access to Sean Lee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean Lee's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings40 Last 1 YearsBuy Recommendations92.50% 37 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution40RatingsDistribution of strong buy, buy, hold, and sell ratings by Sean Lee.RatingPercentageCount Strong Buy2.5%1 ratings Buy90.0%36 ratings Hold7.5%3 ratings Sell0.0%0 ratingsOut of 40 total stock ratings issued by Sean Lee at HC Wainwright, the majority (90.0%) have been Buy recommendations, followed by 7.5% Hold and 2.5% Strong Buy.Best & Worst CallsBest Call0000.0%MNPRJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CASIApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ92.3% of companies on NASDAQ12 companiesNYSEAMERICAN7.7% of companies on NYSEAMERICAN1 companySean Lee, an analyst at HC Wainwright, currently covers 13 companies listed on NASDAQ and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare13 companies100.0%Sean Lee of HC Wainwright specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY6 companies46.2%HEALTHCARE EQUIPMENT & SUPPLIES4 companies30.8%PHARMACEUTICALS3 companies23.1% Sean Lee's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsDWTXDogwood Therapeutics5/19/2026Reiterated Rating$1.70$12.00Buy$0.0000.00% ROISENSSenseonics Holdings, Inc. Common Stock5/12/2026Lower Price Target$5.77$14.00Buy$0.0000.00% ROIATECAlphatec5/7/2026Reiterated Rating$6.99$24.00Buy$0.0000.00% ROIDWTXDogwood Therapeutics4/27/2026Reiterated Rating$1.38$12.00Buy$0.0000.00% ROIAKTXAkari Therapeutics4/1/2026Boost Price Target$4.65$27.00Buy$0.0000.00% ROINVAXNovavax2/27/2026Boost Price Target$11.19$16.00Buy$0.0000.00% ROIDWTXDogwood Therapeutics2/20/2026Reiterated Rating$2.91$12.00Buy$0.0000.00% ROIDWTXDogwood Therapeutics1/30/2026Reiterated Rating$2.90$12.00Buy$0.0000.00% ROIKZIANovogen1/28/2026Reiterated Rating$7.15$18.00Buy$0.0000.00% ROIPSTVPlus Therapeutics1/23/2026Reiterated Rating$7.13$25.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CRVSCorvus Pharmaceuticals1/20/2026Boost Price Target$15.88$27.00Buy$0.0000.00% ROIATECAlphatec1/12/2026Reiterated Rating$17.92$24.00Buy$0.0000.00% ROIKZIANovogen12/12/2025Boost Price Target$13.08$18.00Buy$0.0000.00% ROIPSTVPlus Therapeutics11/26/2025Reiterated Rating$15.20$50.00Buy$0.0000.00% ROICTSOCytosorbents11/14/2025Lower Price Target$0.67$0.75Neutral$0.0000.00% ROISENSSenseonics Holdings, Inc. Common Stock11/6/2025Boost Price Target$6.73$18.50Buy$0.0000.00% ROIPSTVPlus Therapeutics11/3/2025Lower Price Target$13.58$50.00Buy$0.0000.00% ROIATECAlphatec10/31/2025Boost Price Target$16.33$24.00Buy$0.0000.00% ROINVAXNovavax10/23/2025Boost Price Target$8.37$11.00Buy$0.0000.00% ROIDWTXDogwood Therapeutics9/30/2025Boost Price Target$7.91$12.00Buy$0.0000.00% ROIAKTXAkari Therapeutics9/9/2025Reiterated Rating$34.00$64.00Buy$0.0000.00% ROICASICASI Pharmaceuticals9/3/2025Reiterated Rating$2.30$4.00Buy$0.0000.00% ROINVAXNovavax8/28/2025Initiated Coverage$7.58$10.00Buy$0.0000.00% ROIMYOMyomo8/12/2025Lower Price Target$1.76$5.00Buy$0.0000.00% ROIKZIANovogen7/10/2025Upgrade$9.53$13.00Strong-Buy$00.0000.00% ROIPSTVPlus Therapeutics6/27/2025Lower Price Target$9.17$75.00Buy$0.0000.00% ROISENSSenseonics Holdings, Inc. Common Stock6/2/2025Set Price Target$10.47$22.00Buy$0.0000.00% ROICASICASI Pharmaceuticals5/19/2025Reiterated Rating$1.94$4.00Buy$0.0000.00% ROICTSOCytosorbents5/15/2025Reiterated Rating$0.81$1.00Neutral$0.0000.00% ROIVSTMVerastem5/9/2025Boost Price Target$6.94$14.00Buy$0.0000.00% ROIDWTXDogwood Therapeutics4/23/2025Upgrade$5.46$10.00Buy$0.0000.00% ROIATECAlphatec4/14/2025Reiterated Rating$9.75$20.00Buy$00.0000.00% ROICASICASI Pharmaceuticals4/9/2025Lower Price Target$2.05$4.00Buy$0.0000.00% ROICTSOCytosorbents4/3/2025Reiterated Rating$1.00$1.00Neutral$0.0000.00% ROIMNPRMonopar Therapeutics4/1/2025Reiterated Rating$36.41$40.00Buy$00.0000.00% ROIPSTVPlus Therapeutics3/28/2025Lower Price Target$38.00$137.50Buy$0.0000.00% ROIVSTMVerastem3/24/2025Boost Price Target$6.65$10.00Buy$0.0000.00% ROIMYOMyomo3/12/2025Boost Price Target$5.87$9.50Buy$0.0000.00% ROIMNPRMonopar Therapeutics1/22/2025Boost Price Target$31.68$40.00Buy$00.0000.00% ROIATECAlphatec1/14/2025Reiterated Rating$10.88$20.00Buy$00.0000.00% ROITrump's Next Move Could Shrink Your Dollar (Ad)There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. dollar through tariffs, currency pressure, and coordinated policy shifts designed to boost American exports. A weaker dollar means every dollar you've saved buys less - quietly, without a headline or a warning. Smart investors are already repositioning before the slide accelerates.Discover 3 strategies to protect your wealth from a falling dollar Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenBarclaysRoyal Bank Of CanadaMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupBMO Capital MarketsSanford C. BernsteinBerenberg BankBNP Paribas ExaneCompass PointPiper SandlerCanadian Imperial Bank of CommerceWeiss RatingsUBS Group Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
